Not better but quite good: effects on work loss of combination treatment for rheumatoid arthritis with and without biological agents
- PMID: 23817526
- PMCID: PMC3921898
- DOI: 10.1001/jamainternmed.2013.7812
Not better but quite good: effects on work loss of combination treatment for rheumatoid arthritis with and without biological agents
Comment on
-
Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.JAMA Intern Med. 2013 Aug 12;173(15):1407-14. doi: 10.1001/jamainternmed.2013.7801. JAMA Intern Med. 2013. PMID: 23817631 Clinical Trial.
References
-
- Eriksson J, Neovius M, Bratt J, et al. Biologic versus conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial. JAMA Int Med. in press. - PubMed
-
- van Vollenhoven RF, Geborek P, Forslind K, et al. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. Lancet. 2012;379:1712–1720. - PubMed
-
- Yelin E, Henke C, Epstein W. Work dynamics of the person with rheumatoid arthritis. Arthritis Rheum. 1987;30:507–512. - PubMed
-
- Yelin E, Nevitt M, Epstein W. Toward an epidemiology of work disability. Milbank Memorial Fund Quarterly: Health and Society. 1980;58:386–415. - PubMed
-
- LaCaille D. Arthritis and employment research: where are we? Where do we need to go? J Rheumatol Suppl. 2005;72:42–45. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical